Showing results (1-10 of 311) with videos related to
Sort By:
Pageof 32
Neurobiology of Disease|May 5, 2022
Evidence for immune system alterations in peripheral biological fluids in Parkinson's diseaseMichael Bartl, Mary Xylaki, Mathias Bähr, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 14, 2023
Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta-AnalysisMary Xylaki, Avika Chopra, Sandrina Weber, et al.Journal of Parkinson'S Disease|November 1, 2021
Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's DiseaseMichael Bartl, Mohammed Dakna, Sebastian Schade, et al.Parkinsonism & Related Disorders|November 23, 2013
Quantification of α-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson's disease?Brit MollenhauerMovement Disorders : Official Journal of the Movement Disorder Society|April 9, 2025
Anosmia and Upper Limb Rigidity-A Potential Phenotype of Idiopathic Normal Pressure Hydrocephalus with Cerebrospinal Fluid α-Synuclein SeedsSandrina Weber, Carly M Farris, Yihua Ma, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 18, 2012
Biochemical premotor biomarkers for Parkinson's diseaseBrit Mollenhauer, Jing ZhangMovement Disorders : Official Journal of the Movement Disorder Society|May 5, 2009
Neurochemical biomarkers in the differential diagnosis of movement disordersBrit Mollenhauer, Claudia TrenkwalderInternational Journal of Molecular Sciences|December 11, 2025
Proteomic Exploration of L1CAM+-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson's DiseaseMary Xylaki, Avika Chopra, Yevheniia Kyriachenko, et al.Methods in Molecular Biology (Clifton, N.J.)|February 17, 2019
Quantification of Alpha-Synuclein in Biological Fluids by Electrochemiluminescence-Based DetectionNiels Kruse, Brit MollenhauerAlzheimer'S Research & Therapy|December 6, 2014
Biomarkers in biological fluids for dementia with Lewy bodiesSebastian Schade, Brit MollenhauerPageof 32